Skip to main content
. Author manuscript; available in PMC: 2014 Aug 28.
Published in final edited form as: J Registry Manag. 2011 Winter;38(4):201–205.

Table 1.

Reported liver and intrahepatic cancer cases, by site, SEER 17, 1978–2007*

Histological classification (ICD-O) Liver IHBD Total
Class: Carcinoma 51,504 6,483 57,987
 Group:  Hepatocellular carcinoma 44,080 40 44,120
 Group:  Cholangiocarcinoma 3,483 5,565 9,048
 Group:  Other specified carcinoma 1,322 722 2,044
 Group:  Poorly specified carcinoma 2,619 156 2,775
Class:  Hepatoblastoma 527 0 527
Class: Sarcoma ~ ~ 500
 Group: Hemangiosarcoma ~ ~ 190
 Group:  Hemangioendothelioma 77 0 77
 Group:  Other sarcoma ~ ~ 233
Class:  Embryonal sarcoma 65 0 65
Class: Other specified malignancy ~ ~ 33
 Group:  Germ cell tumor ~ ~ 12
 Group:  Carcinosarcoma, NOS ~ ~ 20
 Group:  Malignant melanoma, NOS ~ ~ ~
Class: Poorly specified malignancy 2,719 159 2,878
All liver and intrahepatic cancer cases combined 55,344 6,646 61,990
*

International Classification of Diseases for Oncology

IHBD: Intrahepatic Bile Duct

Source: Incidence-SEER 17, Nov 2009 File, Katrina/Rita Population Adjustment, 1973–2007 varying

~

Data were suppressed when site specific or total counts included less than 12 cases. Zero counts were allowed.